Quest Di­ag­nos­tics buys Bert Vo­gel­stein’s Haystack On­col­o­gy, just six months af­ter Se­ries A

Quest Di­ag­nos­tics is buy­ing can­cer de­tec­tion start­up Haystack On­col­o­gy for $300 mil­lion in cash, with plans to launch a new can­cer lab test in 2024 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.